152 related articles for article (PubMed ID: 7370238)
1. Evidence of a specific complex between adriamycin and negatively-charged phospholipids.
Goormaghtigh E; Chatelain P; Caspers J; Ruysschaert JM
Biochim Biophys Acta; 1980 Mar; 597(1):1-14. PubMed ID: 7370238
[TBL] [Abstract][Full Text] [Related]
2. Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites.
Henry N; Fantine EO; Bolard J; Garnier-Suillerot A
Biochemistry; 1985 Dec; 24(25):7085-92. PubMed ID: 4084563
[TBL] [Abstract][Full Text] [Related]
3. Effects of adriamycin on lipid polymorphism in cardiolipin-containing model and mitochondrial membranes.
Nicolay K; van der Neut R; Fok JJ; de Kruijff B
Biochim Biophys Acta; 1985 Sep; 819(1):55-65. PubMed ID: 4041451
[TBL] [Abstract][Full Text] [Related]
4. On the reversal by deoxyribonucleic acid of the binding of adriamycin to cardiolipin-containing liposomes.
Mustonen P; Kinnunen PK
J Biol Chem; 1993 Jan; 268(2):1074-80. PubMed ID: 7678246
[TBL] [Abstract][Full Text] [Related]
5. 10N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria.
Petit JM; Maftah A; Ratinaud MH; Julien R
Eur J Biochem; 1992 Oct; 209(1):267-73. PubMed ID: 1396703
[TBL] [Abstract][Full Text] [Related]
6. Binding of adriamycin-Fe3+ complex to membrane phospholipids.
Demant EJ
Eur J Biochem; 1984 Aug; 142(3):571-5. PubMed ID: 6468379
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of the selectivity of adriamycin for negatively-charged phospholipids by 14-valerate side chain substitution.
Burke TG; Israel M; Seshadri R; Doroshow JH
Cancer Biochem Biophys; 1990 Apr; 11(2):177-85. PubMed ID: 2383860
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of inhibition of mitochondrial enzymatic complex I-III by adriamycin derivatives.
Goormaghtigh E; Huart P; Brasseur R; Ruysschaert JM
Biochim Biophys Acta; 1986 Sep; 861(1):83-94. PubMed ID: 3019400
[TBL] [Abstract][Full Text] [Related]
9. Study of the adriamycin-cardiolipin complex structure using attenuated total reflection infrared spectroscopy.
Goormaghtigh E; Brasseur R; Huart P; Ruysschaert JM
Biochemistry; 1987 Mar; 26(6):1789-94. PubMed ID: 3593690
[TBL] [Abstract][Full Text] [Related]
10. The interaction of adriamycin with small unilamellar vesicle liposomes. A fluorescence study.
Karczmar GS; Tritton TR
Biochim Biophys Acta; 1979 Nov; 557(2):306-19. PubMed ID: 583025
[TBL] [Abstract][Full Text] [Related]
11. Interaction of adriamycin with human erythrocyte membranes. Role of the negatively charged phospholipids.
Garnier-Suillerot A; Gattegno L
Biochim Biophys Acta; 1988 Oct; 936(1):50-60. PubMed ID: 2972315
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.
Gallois L; Fiallo M; Garnier-Suillerot A
Biochim Biophys Acta; 1998 Mar; 1370(1):31-40. PubMed ID: 9518541
[TBL] [Abstract][Full Text] [Related]
13. A comparative model membrane study on structural effects of membrane-active positively charged anti-tumor drugs.
Nicolay K; Sautereau AM; Tocanne JF; Brasseur R; Huart P; Ruysschaert JM; de Kruijff B
Biochim Biophys Acta; 1988 May; 940(2):197-208. PubMed ID: 3163502
[TBL] [Abstract][Full Text] [Related]
14. The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes.
Nicolay K; Timmers RJ; Spoelstra E; Van der Neut R; Fok JJ; Huigen YM; Verkleij AJ; De Kruijff B
Biochim Biophys Acta; 1984 Dec; 778(2):359-71. PubMed ID: 6498197
[TBL] [Abstract][Full Text] [Related]
15. [Changes of the phospholipid bilayer structure under the adsorption of ferricytochrome c on its surface].
Obraztsov VV; Kobelev VS; Tenchov BI; Selishcheva AA; Sibel'dina LA
Biokhimiia; 1976 Nov; 41(11):2015-20. PubMed ID: 191102
[TBL] [Abstract][Full Text] [Related]
16. Interactions of cytochrome c and [14C].
Quinn PJ; Dawson RM
Biochem J; 1969 Oct; 115(1):65-75. PubMed ID: 5388143
[TBL] [Abstract][Full Text] [Related]
17. Physical and chemical modifications of adriamycin:iron complex by phospholipid bilayers.
Samuni A; Chong PL; Barenholz Y; Thompson TE
Cancer Res; 1986 Feb; 46(2):594-9. PubMed ID: 3940630
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group.
Burke TG; Sartorelli AC; Tritton TR
Cancer Chemother Pharmacol; 1988; 21(4):274-80. PubMed ID: 3370735
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for the binding of antitumor anthracycline antibiotics to model membranes: circular dichroism studies.
Henry-Toulme N; Stefanska B; Borowski E; Bolard J
Mol Pharmacol; 1988 May; 33(5):574-9. PubMed ID: 3367905
[TBL] [Abstract][Full Text] [Related]
20. Coverage-dependent changes of cytochrome c transverse location in phospholipid membranes revealed by FRET.
Domanov YA; Molotkovsky JG; Gorbenko GP
Biochim Biophys Acta; 2005 Oct; 1716(1):49-58. PubMed ID: 16183372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
